IMPORTANT INFORMATION COVID19
Dear Friends and Colleagues,
As you are aware, the Coronavirus (COVID-19) pandemic has forced us to postpone this year’s SIOP-Europe Annual Meeting, and the new dates for the Meeting are 26-30 April 2021 in Valencia.
The same was obviously necessary for the 12th Biennial Childhood Leukemia and Lymphoma Symposium (CLLS) which will therefore be held on 24 and 25 April 2021 at Hotel Melia, still in Valencia.
In the current climate many may have some questions relating to the latest developments of the COVID 19 pandemic and how these could affect the CLLS 2021. Please review on the CLLS 2021 website the FAQ which will continue to be updated as any additional questions will be received.
We hope that as many of you as possible could be present in Valencia in April 2021, both for CLLS and for the SIOPE Annual Meeting. Together we will make these Meetings a special and memorable event.
Should you require any further information, please do not hesitate to contact the CLLS Secretariat: info@clls2021.org
With our best wishes,
Andrea Biondi, Andishe Attarbaschi
IMPORTANT DATES
New Symposium
date!
New Abstract
Submission deadline
Early Fee
deadline
WELCOME
WELCOME FROM THE I-BFM CHAIR
It is my great pleasure to welcome you all to the the 12th I-BFM Biennial Childhood Leukemia and Lymphoma Symposium (CLLS). We are very glad to have our traditional meeting hosted for the first time in Spain, in Valencia. We will be in a special country, and I am sure it will be a special meeting!
Since the beginning, we thought to have the CLLS meeting as an important opportunity for fellows, researchers and junior faculty to highlight novel basic and clinical information on malignant hematological malignancies. The keynote topics of this conference are acute lymphoblastic leukemia (ALL), translational research in ALL and lymphoma, immunotherapy and targeted agents in leukemia and lymphoma, myeloid disorders, therapy and outcome of leukemia and lymphoma in low- and middle-income countries, optimal supportive care in malignant hematologic malignancies, amongst others...
TOPICS
Topics
- Biology and Translational Research of Primary and Relapsed/Refractory Acute Leukemias and Lymphomas
- Therapy and Outcome of Acute Leukemias and Lymphomas in Low- and Middle-Income Countries
- Myelodysplastic and Myeloproliferative Disorders
- Cellular Therapies of Acute Leukemias and Lymphomas
- Optimal Supportive Care in Leukemia and Lymphoma
PARTNERSHIP / COLLABORATION
